Aripiprazole |
7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril |
(CAS 129722-12-9) |
 |
Description: |
Aripiprazole(Abilify) is a human 5-HT1A receptor partial agonist with a Ki of 4.2 nM.
IC50 Value: 4.2 nM(Ki)
Target: 5-HT Receptor
Aripiprazole is an atypical antipsychotic medication used for the treatment of schizophrenia. It has also recently received FDA approval for the treatment of acute manic and mixed episodes associated with bipolar disorder. Aripiprazole appears to mediate its antipsychotic effects primarily by partial agonism at the D2 receptor. In addition to partial agonist activity at the D2 receptor, aripiprazole is also a partial agonist at the 5-HT1A receptor, and like the other atypical antipsychotics, aripiprazole displays an antagonist profile at the 5-HT2A receptor. Aripiprazole has moderate affinity for histamine and alpha adrenergic receptors, and no appreciable affinity for cholinergic muscarinic receptors.
|
Product No. |
KT20220 |
Product Name |
Aripiprazole |
Synonyms |
Abilify |
Formal Name |
7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril |
CAS Number |
129722-12-9 |
Molecular Formula |
C23H27Cl2N3O2 |
Formula Weight |
448.39 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
Asenapine
Azaphen
Azasetron
Bilobalide
Blonanserin
BRL 54443
BRL-15572
Cisapride
Clozapine N-oxide
CP-809101
Cyclobenzaprine hydrochloride
Dapoxetine Hydrochloride
Desvenlafaxine
Dihydroergotamine mesylate
Doxepin
Duloxetine
Eletriptan
Eltoprazine
|
|